The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study

被引：0
作者：
Yu-Guang Chen
Chih-Wei Yang
Chi-Hsiang Chung
Ching-Liang Ho
Wei-Liang Chen
Wu-Chien Chien
机构：
[1] Tri-Service General Hospital,Division of Hematology/Oncology, Department of Internal Medicine
[2] National Defense Medical Center,Cancer Institute
[3] University College London,Division of Gastroenterology, Department of Internal Medicine
[4] Tri-Service General Hospital,School of Public Health
[5] National Defense Medical Center,Department of Medical Research
[6] National Defense Medical Center,Department of Family Medicine
[7] Tri-Service General Hospital,undefined
[8] National Defense Medical Center,undefined
[9] Tri-Service General Hospital,undefined
[10] National Defense Medical Center,undefined
来源：
Hepatology International | 2022年 / 16卷
关键词：
Metabolic syndrome; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Hepatocellular carcinoma; Epidemiology; Clinical research; Cirrhosis of liver; National Health Insurance Research Database;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：807 / 816
页数：9
相关论文
共 119 条
  • [1] Yang J(2012)Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling World J Gastroenterol 18 2938-2947
  • [2] Zhang JX(2021)Hepatocellular carcinoma: an overview of the changing landscape of treatment options J Hepatocell Carcinoma 8 387-401
  • [3] Wang H(2017)Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis J Carcinog 16 1-752
  • [4] Wang GL(2006)Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults J Clin Gastroenterol 40 745-2123
  • [5] Hu QG(2007)Significant correlations between severe fatty liver and risk factors for metabolic syndrome J Gastroenterol Hepatol 22 2118-788
  • [6] Zheng QC(2010)Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites Hepatology 52 774-117
  • [7] Koulouris A(2014)Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team J Hepatol 60 110-873
  • [8] Tsagkaris C(2017)New trends on obesity and NAFLD in Asia J Hepatol 67 862-1314
  • [9] Spyrou V(2017)The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease Int J Cancer 141 1307-209
  • [10] Pappa E(2020)A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement J Hepatol 73 202-919
12345678910